S&P 500   5,069.53
DOW   39,069.23
QQQ   436.55
Is CRISPR Therapeutics the NVIDIA of gene editing?
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
These 2 carnivore dining stocks gaining on the Ozempic craze
This healthcare stock making a buzz with 160% growth
Critical asset just had biggest fall on record (Ad)
First it was Tyson stock, now this food company is set to rally
6 reasons to buy Teva Pharmaceuticals stock sooner than later
Critical asset just had biggest fall on record (Ad)
How major US stock indexes fared Monday, 2/26/2024
This infrastructure construction stock: Is it ready to pop?
S&P 500   5,069.53
DOW   39,069.23
QQQ   436.55
Is CRISPR Therapeutics the NVIDIA of gene editing?
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
These 2 carnivore dining stocks gaining on the Ozempic craze
This healthcare stock making a buzz with 160% growth
Critical asset just had biggest fall on record (Ad)
First it was Tyson stock, now this food company is set to rally
6 reasons to buy Teva Pharmaceuticals stock sooner than later
Critical asset just had biggest fall on record (Ad)
How major US stock indexes fared Monday, 2/26/2024
This infrastructure construction stock: Is it ready to pop?
S&P 500   5,069.53
DOW   39,069.23
QQQ   436.55
Is CRISPR Therapeutics the NVIDIA of gene editing?
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
These 2 carnivore dining stocks gaining on the Ozempic craze
This healthcare stock making a buzz with 160% growth
Critical asset just had biggest fall on record (Ad)
First it was Tyson stock, now this food company is set to rally
6 reasons to buy Teva Pharmaceuticals stock sooner than later
Critical asset just had biggest fall on record (Ad)
How major US stock indexes fared Monday, 2/26/2024
This infrastructure construction stock: Is it ready to pop?
S&P 500   5,069.53
DOW   39,069.23
QQQ   436.55
Is CRISPR Therapeutics the NVIDIA of gene editing?
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
These 2 carnivore dining stocks gaining on the Ozempic craze
This healthcare stock making a buzz with 160% growth
Critical asset just had biggest fall on record (Ad)
First it was Tyson stock, now this food company is set to rally
6 reasons to buy Teva Pharmaceuticals stock sooner than later
Critical asset just had biggest fall on record (Ad)
How major US stock indexes fared Monday, 2/26/2024
This infrastructure construction stock: Is it ready to pop?

Phoenix Biotech Acquisition (PBAX) SEC Filings & 10K Form

$5.85
+0.26 (+4.65%)
(As of 02/14/2024)

Recent Phoenix Biotech Acquisition SEC Filings

DateFilerForm TypeView
02/26/2024
8:37 PM
CERO THERAPEUTICS HOLDINGS, INC. (Issuer)
Phoenix Biotech Acquisition (Issuer)
CERO THERAPEUTICS HOLDINGS, INC. (Issuer)
CERO THERAPEUTICS HOLDINGS, INC. (Issuer)
Corey Daniel (Reporting)
Form 3/A
02/23/2024
4:13 PM
CERO THERAPEUTICS HOLDINGS, INC. (Filer)
Phoenix Biotech Acquisition (Filer)
CERO THERAPEUTICS HOLDINGS, INC. (Filer)
CERO THERAPEUTICS HOLDINGS, INC. (Filer)
Form D
Notice of Exempt Offering of Securities 
02/22/2024
8:06 AM
CERO THERAPEUTICS HOLDINGS, INC. (Subject)
Phoenix Biotech Acquisition (Subject)
CERO THERAPEUTICS HOLDINGS, INC. (Subject)
CERO THERAPEUTICS HOLDINGS, INC. (Subject)
Shaolin Capital Management LLC (Filed by)
Form SC 13G/A
02/21/2024
4:57 PM
CERO THERAPEUTICS HOLDINGS, INC. (Issuer)
Phoenix Biotech Acquisition (Issuer)
CERO THERAPEUTICS HOLDINGS, INC. (Issuer)
CERO THERAPEUTICS HOLDINGS, INC. (Issuer)
LAPORTE KATHLEEN (Reporting)
Form 4/A
02/16/2024
6:37 PM
CERO THERAPEUTICS HOLDINGS, INC. (Issuer)
Phoenix Biotech Acquisition (Issuer)
CERO THERAPEUTICS HOLDINGS, INC. (Issuer)
CERO THERAPEUTICS HOLDINGS, INC. (Issuer)
Ehrlich Christopher B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2024
6:37 PM
CERO THERAPEUTICS HOLDINGS, INC. (Issuer)
Phoenix Biotech Acquisition (Issuer)
CERO THERAPEUTICS HOLDINGS, INC. (Issuer)
CERO THERAPEUTICS HOLDINGS, INC. (Issuer)
LAPORTE KATHLEEN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2024
6:38 PM
CERO THERAPEUTICS HOLDINGS, INC. (Issuer)
Phoenix Biotech Acquisition (Issuer)
CERO THERAPEUTICS HOLDINGS, INC. (Issuer)
CERO THERAPEUTICS HOLDINGS, INC. (Issuer)
PHOENIX BIOTECH SPONSOR, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2024
6:39 PM
CERO THERAPEUTICS HOLDINGS, INC. (Issuer)
Phoenix Biotech Acquisition (Issuer)
CERO THERAPEUTICS HOLDINGS, INC. (Issuer)
CERO THERAPEUTICS HOLDINGS, INC. (Issuer)
Fisher Douglas Carl (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2024
6:39 PM
CERO THERAPEUTICS HOLDINGS, INC. (Issuer)
Phoenix Biotech Acquisition (Issuer)
CERO THERAPEUTICS HOLDINGS, INC. (Issuer)
CERO THERAPEUTICS HOLDINGS, INC. (Issuer)
Geffken Daniel E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2024
6:40 PM
CERO THERAPEUTICS HOLDINGS, INC. (Issuer)
Phoenix Biotech Acquisition (Issuer)
CERO THERAPEUTICS HOLDINGS, INC. (Issuer)
CERO THERAPEUTICS HOLDINGS, INC. (Issuer)
Kosacz Barbara (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2024
6:41 PM
CERO THERAPEUTICS HOLDINGS, INC. (Issuer)
Phoenix Biotech Acquisition (Issuer)
CERO THERAPEUTICS HOLDINGS, INC. (Issuer)
CERO THERAPEUTICS HOLDINGS, INC. (Issuer)
Loewy Caroline M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2024
6:27 PM
Byrnes Michael (Reporting)
CERO THERAPEUTICS HOLDINGS, INC. (Issuer)
Phoenix Biotech Acquisition (Issuer)
CERO THERAPEUTICS HOLDINGS, INC. (Issuer)
CERO THERAPEUTICS HOLDINGS, INC. (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
02/16/2024
6:28 PM
Carter Charles Ross (Reporting)
CERO THERAPEUTICS HOLDINGS, INC. (Issuer)
Phoenix Biotech Acquisition (Issuer)
CERO THERAPEUTICS HOLDINGS, INC. (Issuer)
CERO THERAPEUTICS HOLDINGS, INC. (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
02/16/2024
6:28 PM
CERO THERAPEUTICS HOLDINGS, INC. (Issuer)
Phoenix Biotech Acquisition (Issuer)
CERO THERAPEUTICS HOLDINGS, INC. (Issuer)
CERO THERAPEUTICS HOLDINGS, INC. (Issuer)
Corey Daniel (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/16/2024
6:29 PM
CERO THERAPEUTICS HOLDINGS, INC. (Issuer)
Phoenix Biotech Acquisition (Issuer)
CERO THERAPEUTICS HOLDINGS, INC. (Issuer)
CERO THERAPEUTICS HOLDINGS, INC. (Issuer)
Rapaport Robyn (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/16/2024
6:29 PM
CERO THERAPEUTICS HOLDINGS, INC. (Issuer)
Phoenix Biotech Acquisition (Issuer)
CERO THERAPEUTICS HOLDINGS, INC. (Issuer)
CERO THERAPEUTICS HOLDINGS, INC. (Issuer)
Rolfe Lindsey (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/16/2024
6:36 PM
ATWOOD BRIAN G (Reporting)
CERO THERAPEUTICS HOLDINGS, INC. (Issuer)
Phoenix Biotech Acquisition (Issuer)
CERO THERAPEUTICS HOLDINGS, INC. (Issuer)
CERO THERAPEUTICS HOLDINGS, INC. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
11:12 AM
PHOENIX BIOTECH ACQUISITION CORP. (Filer)
Phoenix Biotech Acquisition (Filer)
PHOENIX BIOTECH ACQUISITION CORP. (Filer)
PHOENIX BIOTECH ACQUISITION CORP. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2024
11:14 AM
PHOENIX BIOTECH ACQUISITION CORP. (Subject)
Phoenix Biotech Acquisition (Subject)
PHOENIX BIOTECH ACQUISITION CORP. (Subject)
PHOENIX BIOTECH ACQUISITION CORP. (Subject)
Form 425
02/08/2024
11:31 AM
PHOENIX BIOTECH ACQUISITION CORP. (Subject)
Phoenix Biotech Acquisition (Subject)
PHOENIX BIOTECH ACQUISITION CORP. (Subject)
PHOENIX BIOTECH ACQUISITION CORP. (Subject)
Saba Capital Management, L.P. (Filed by)
Form SC 13G/A
02/06/2024
5:20 AM
PHOENIX BIOTECH ACQUISITION CORP. (Filer)
Phoenix Biotech Acquisition (Filer)
PHOENIX BIOTECH ACQUISITION CORP. (Filer)
PHOENIX BIOTECH ACQUISITION CORP. (Filer)
Form 424B3
02/06/2024
5:11 AM
PHOENIX BIOTECH ACQUISITION CORP. (Filer)
Phoenix Biotech Acquisition (Filer)
PHOENIX BIOTECH ACQUISITION CORP. (Filer)
PHOENIX BIOTECH ACQUISITION CORP. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/06/2024
5:14 AM
PHOENIX BIOTECH ACQUISITION CORP. (Subject)
Phoenix Biotech Acquisition (Subject)
PHOENIX BIOTECH ACQUISITION CORP. (Subject)
PHOENIX BIOTECH ACQUISITION CORP. (Subject)
Form 425
01/22/2024
4:29 PM
PHOENIX BIOTECH ACQUISITION CORP. (Filer)
Phoenix Biotech Acquisition (Filer)
PHOENIX BIOTECH ACQUISITION CORP. (Filer)
PHOENIX BIOTECH ACQUISITION CORP. (Filer)
Form DEFM14A
01/22/2024
4:27 PM
PHOENIX BIOTECH ACQUISITION CORP. (Filer)
Phoenix Biotech Acquisition (Filer)
PHOENIX BIOTECH ACQUISITION CORP. (Filer)
PHOENIX BIOTECH ACQUISITION CORP. (Filer)
Form 424B3
01/21/2024
11:15 PM
PHOENIX BIOTECH ACQUISITION CORP. (Filer)
Phoenix Biotech Acquisition (Filer)
PHOENIX BIOTECH ACQUISITION CORP. (Filer)
PHOENIX BIOTECH ACQUISITION CORP. (Filer)
Form EFFECT
01/08/2024
6:31 PM
PHOENIX BIOTECH ACQUISITION CORP. (Filer)
Phoenix Biotech Acquisition (Filer)
PHOENIX BIOTECH ACQUISITION CORP. (Filer)
PHOENIX BIOTECH ACQUISITION CORP. (Filer)
Form S-4/A
01/05/2024
3:08 PM
PHOENIX BIOTECH ACQUISITION CORP. (Subject)
Phoenix Biotech Acquisition (Subject)
PHOENIX BIOTECH ACQUISITION CORP. (Subject)
PHOENIX BIOTECH ACQUISITION CORP. (Subject)
Form 425
12/15/2023
7:46 PM
PHOENIX BIOTECH ACQUISITION CORP. (Filer)
Phoenix Biotech Acquisition (Filer)
PHOENIX BIOTECH ACQUISITION CORP. (Filer)
PHOENIX BIOTECH ACQUISITION CORP. (Filer)
Form S-4/A
12/14/2023
3:37 PM
PHOENIX BIOTECH ACQUISITION CORP. (Filer)
Phoenix Biotech Acquisition (Filer)
PHOENIX BIOTECH ACQUISITION CORP. (Filer)
PHOENIX BIOTECH ACQUISITION CORP. (Filer)
Form DEF 14A
11/09/2023
3:01 PM
PHOENIX BIOTECH ACQUISITION CORP. (Filer)
Phoenix Biotech Acquisition (Filer)
PHOENIX BIOTECH ACQUISITION CORP. (Filer)
PHOENIX BIOTECH ACQUISITION CORP. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
09/08/2023
3:35 PM
PHOENIX BIOTECH ACQUISITION CORP. (Subject)
Phoenix Biotech Acquisition (Subject)
PHOENIX BIOTECH ACQUISITION CORP. (Subject)
PHOENIX BIOTECH ACQUISITION CORP. (Subject)
Form 425
07/19/2023
7:33 AM
PHOENIX BIOTECH ACQUISITION CORP. (Filer)
Phoenix Biotech Acquisition (Filer)
PHOENIX BIOTECH ACQUISITION CORP. (Filer)
PHOENIX BIOTECH ACQUISITION CORP. (Filer)
Form S-4/A
07/18/2023
3:05 PM
PHOENIX BIOTECH ACQUISITION CORP. (Filer)
Phoenix Biotech Acquisition (Filer)
PHOENIX BIOTECH ACQUISITION CORP. (Filer)
PHOENIX BIOTECH ACQUISITION CORP. (Filer)
Form 8-K/A
07/18/2023
3:06 PM
PHOENIX BIOTECH ACQUISITION CORP. (Subject)
Phoenix Biotech Acquisition (Subject)
PHOENIX BIOTECH ACQUISITION CORP. (Subject)
PHOENIX BIOTECH ACQUISITION CORP. (Subject)
Form 425
07/10/2023
4:12 PM
PHOENIX BIOTECH ACQUISITION CORP. (Filer)
Phoenix Biotech Acquisition (Filer)
PHOENIX BIOTECH ACQUISITION CORP. (Filer)
PHOENIX BIOTECH ACQUISITION CORP. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/10/2023
4:15 PM
PHOENIX BIOTECH ACQUISITION CORP. (Subject)
Phoenix Biotech Acquisition (Subject)
PHOENIX BIOTECH ACQUISITION CORP. (Subject)
PHOENIX BIOTECH ACQUISITION CORP. (Subject)
Form 425
07/03/2023
12:10 PM
PHOENIX BIOTECH ACQUISITION CORP. (Filer)
Phoenix Biotech Acquisition (Filer)
PHOENIX BIOTECH ACQUISITION CORP. (Filer)
PHOENIX BIOTECH ACQUISITION CORP. (Filer)
Form DEFA14A
07/03/2023
12:11 PM
PHOENIX BIOTECH ACQUISITION CORP. (Filer)
Phoenix Biotech Acquisition (Filer)
PHOENIX BIOTECH ACQUISITION CORP. (Filer)
PHOENIX BIOTECH ACQUISITION CORP. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/03/2023
12:14 PM
PHOENIX BIOTECH ACQUISITION CORP. (Subject)
Phoenix Biotech Acquisition (Subject)
PHOENIX BIOTECH ACQUISITION CORP. (Subject)
PHOENIX BIOTECH ACQUISITION CORP. (Subject)
Form 425
06/05/2023
8:26 AM
PHOENIX BIOTECH ACQUISITION CORP. (Subject)
Phoenix Biotech Acquisition (Subject)
PHOENIX BIOTECH ACQUISITION CORP. (Subject)
PHOENIX BIOTECH ACQUISITION CORP. (Subject)
Form 425
06/05/2023
8:23 AM
PHOENIX BIOTECH ACQUISITION CORP. (Filer)
Phoenix Biotech Acquisition (Filer)
PHOENIX BIOTECH ACQUISITION CORP. (Filer)
PHOENIX BIOTECH ACQUISITION CORP. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/19/2023
8:00 AM
PHOENIX BIOTECH ACQUISITION CORP. (Filer)
Phoenix Biotech Acquisition (Filer)
PHOENIX BIOTECH ACQUISITION CORP. (Filer)
PHOENIX BIOTECH ACQUISITION CORP. (Filer)
Form PRE 14A
04/07/2023
3:30 PM
PHOENIX BIOTECH ACQUISITION CORP. (Filer)
Phoenix Biotech Acquisition (Filer)
PHOENIX BIOTECH ACQUISITION CORP. (Filer)
PHOENIX BIOTECH ACQUISITION CORP. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/23/2023
6:43 PM
PHOENIX BIOTECH ACQUISITION CORP. (Filer)
Phoenix Biotech Acquisition (Filer)
PHOENIX BIOTECH ACQUISITION CORP. (Filer)
PHOENIX BIOTECH ACQUISITION CORP. (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:PBAX) was last updated on 2/27/2024 by MarketBeat.com Staff